Drug Delivery Market Research

Total Records (46)
Show

Neonatal Intensive Care Respiratory Devices Market By Device (Nebulizers, Inhalers, Ventilators, Continuous Positive Airway Pressure Devices, Apnea Monitors), By End User (NICU Hospitals, Specialty Clinics, Nursing Homes) - Growth, Future Prospects & Competitive Analysis, 2019 – 2027

The global neonatal intensive care respiratory devices market is growing effectively, was valued at US$ 1,396.5 Mn in 2018 and expected to reach US$ 2,134.5 Mn by 2027. Globally increasing breathing disorders in the newborn babies, along with prevalence of respiratory disorders has significantly increased the revenue on a global scale. Acquisitions along with new respiratory equipment and device launches in the neonatal care industry are driving the overall growth in the emerging nations on a global scale.

4325.00
27 May, 2019

Joint Pain Injections Market By Injection (Hyaluronic Acid Injections, Corticosteroid Injections, Others), By Joint (Hip Joint, Knee & Ankle, Shoulder & Elbow, Facet Joints Of The Spine, Others) - Growth, Future Prospects, And Competitive Landscape, 2026 - 2034

The joint pain injections market is set to exhibiting outstanding growth at a compound annual growth rate (CAGR) of 9.7% during the forecast period from 2025 to 2033. As per the latest research citing brought forward by Global Burden of Disease Study the burden associated with musculoskeletal disorders is approximately 6.8% of DALYs worldwide.

4500.00
09 Apr, 2019

Medical Devices Outsourcing Market By Services (Quality Assurance, Regulatory Affairs Services, Product Design And Development, Product Testing And Sterilization, Product Upgrade Services, Product Maintenance Services, Contract Manufacturing), By Application (Cardiology, Diagnostic Imaging, Orthopedic, Diagnostic Testing Systems, Ophthalmic, Drug Delivery, General & Plastic Surgery, Dental, Endoscopy, Diabetes Care) - Growth, Future Prospects, And Competitive Landscape, 2026 - 2034

The global medical devices outsourcing market expected to grow at compound annual growth rate (CAGR) of 10.6% during the forecast period from 2025 to 2033. Outsourcing of medical devices manufacturing has become a pervasive aspect of medical device industry with every company are choosing outsourcing over in-house manufacturing. This has led the companies to focus on their core competencies and new product development. The trend of outsourcing medical devices R&D is also increasing. Outsourcing has become the favorite option for the companies as it reduces costs, accelerate market entry of products and curtails business risks.

4500.00
04 Apr, 2019

Incinerators Market By Product (Fluidized Bed Incinerator, Rotary Kiln Incinerator, Catalytic Combustion Incinerator, Multiple Hearth Incinerator and Liquid Injection Incinerator), By Application (Agricultural, Livestock, Industrial, Municipal and Medical) – Growth, Future Prospects and Competitive Analysis, 2026 - 2034

The global incinerators market growing at CAGR of 4.22% across the forecast period from 2025 to 2033. Rate of waste generation is rising with tremendous pace across the world credited to rapidly growing population along with urbanization trend. In 2020, the solid waste generation across urban areas in the world accounted for 2.01 Bn Tonnes. With such rapid rate, annual waste generation expected to hit the count of 3.40 Bn Tonnes in 2050. Furthermore, rising advancements in technology expected to enhance the performance and provide lucrative opportunities to incinerator manufacturers across the world.

4500.00
21 Mar, 2019

Disposable Medical Supplies Market By Product (Surgical Instruments & Supplies, Infusion & Hypodermic Devices, Drug Delivery Devices, Diagnostic & Laboratory Disposables, Nonwoven Medical Garments & Textiles, Wound Management Supplies, Sterilization Supplies, Respiratory Supplies & Devices, Incontinence Goods, Dialysis Disposables, Medical & Laboratory Gloves, Patient Room Supplies) - Growth, Future Prospects, And Competitive Analysis, 2018 - 2026

The global disposable medical supplies market held US$ 112.6 Bn in 2017 and expected to grow at compound annual growth rate (CAGR) of 6.2% during the forecast period from 2018 to 2026. The market is largely driven by growing hospitalization and volume of surgeries performed, growing chronic diseases and stringent infection prevention control strategies around the world.

4325.00
09 Feb, 2019

Smart Inhalers Market By Type (Metered Dose Inhalers, Dry Powder Inhalers and Nebulizers), By Application (COPD, Asthma and Others) - Growth, Future Prospects & Competitive Analysis, 2018 - 2026

The smart inhalers market is set to reach from US$ 1,006.6 Mn in 2017 to US$ 3,674.6 Mn by 2026 at a compound annual growth rate (CAGR) of 15.7% during the forecast period from 2018 to 2026. Smart inhalers are mounted on respiratory inhalers and nebulizers and provides its services via wireless smart apps and cloud computing systems. They are useful in adjusting the inhaled dose and also reminds the patients regularly by sending alert messages to take medication on time, thereby optimally enhancing patient adherence and compliance with inhaled medications prescribed for chronic respiratory diseases such as COPD and asthma.

4325.00
23 Jan, 2019

Flea and Ticks Product Market By Type (Oral Pill, Spray, Spot On, Powder , Shampoo , Collar , Others (Drops, Injections, Dips)), By Distribution (Vet Store , Pet Superstore, Mass Merchandiser , Online Channel), By Pet type ( Dog Cat , Others (Mice, Rabbit)) - Growth, Share, Opportunities & Competitive Analysis, 2025 – 2033

Flea and ticks are parasites that cause discomfort and illness in pets which can affect humans too. Fleas and ticks can be easily controlled by usage of safe and effective products or by keeping animals far off places where flea and ticks thrive. Tick bites are irritating and painful while the variety of diseases they transmit are anaplasmosis, babesiosis ehrlichiosis etc. Ticks prefer moist, dark and bushy areas to lay eggs.

4500.00
15 Nov, 2022

Respiratory Inhalers Market By Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disorder, Pulmonary Arterial Hypertension, Cystic Fibrosis), By Technology (Digital, Manual) - Growth, Future Prospects & Competitive Analysis, 2025 – 2033

Respiratory inhalers are used to administer an extensive range of medications such as beta-agonists, anticholinergic, corticosteroids and certain antibiotics. Respiratory inhalers are used to provide relief of symptoms in various respiratory conditions such as asthma, chronic obstructive pulmonary disorder (COPD), pulmonary arterial hypertension, bronchitis and cystic fibrosis. In such respiratory conditions both mild and severe symptoms occur such as coughing, shortness of breath, chest congestion, respiratory discomfort and even death in extreme cases. Thus it becomes important to relieve the symptoms immediately which is accomplished by the use of inhalers.

4500.00
29 Nov, 2017

Purging Compounds Market By Type (Mechanical Purging, Chemical/Foaming Purging, Liquid Purging), By Process (Extrusion, Injection Molding, Blow Molding) - Growth, Future Prospects, Competitive Analysis And Forecast 2021 - 2029

The global Purging Compounds market was valued at US$ 450.5 million in 2020. Increasing demand for plastic processing machinery coupled with the benefits offered by the purging compounds such as low material wastage, lower production cost, high efficiency, and reduced machine downtime are a few of the major factors that are expected to fuel the demand for the purging compounds market, globally.

4325.00
05 Nov, 2017

Ocular Drug Delivery Technologies Market By Technology (Topical Medication, Ocular Insert, Ocular Implant), By Indication (Glaucoma , Age Related Macular Degeneration) - Growth, Future Prospects & Competitive Analysis, 2017- 2025

Ocular drug delivery is a cumbersome challenge to the researchers and medical field as the physiology and anatomy of eye is relatively complex. The conventional drugs are available in the market, but they are lesser efficient to act some particular sites of eye. Therefore research for enhanced eye treatment is still an ongoing process to develop advanced technology with better outcome. Topical treatment is the conventional approach and still dominates the market owing to easy application and in terms of affordability.

4325.00
12 Oct, 2017
Filter

Key Sectors

The drug delivery market includes devices, formulations and technologies used to administer pharmaceutical products and biologics to patients. Drug delivery systems are designed to improve treatment effectiveness, control the release of active ingredients, increase patient convenience and deliver medicines to specific areas of the body. The category covers oral, injectable, transdermal, pulmonary, nasal, ocular, topical, transmucosal and implantable delivery systems.

The global drug delivery devices market is expected to demonstrate steady growth through 2035. One current industry estimate projects the market to increase from approximately USD 303.28 billion in 2025 to USD 533.31 billion by 2035, representing a compound annual growth rate of 5.81% during 2026–2035. North America held the largest regional share in 2025, while Asia-Pacific is projected to record notable growth. Oral delivery held a leading position by administration route, while home healthcare is expected to become an important end-user segment.

Increasing prevalence of diabetes, cancer, cardiovascular disorders, respiratory conditions and autoimmune diseases is a major market driver. Patients with chronic conditions frequently require long-term treatment, creating demand for reliable and convenient drug delivery products. Growth in biologics, vaccines, peptides, cell therapies and gene therapies is also increasing the need for specialized delivery systems capable of protecting sensitive medicines and improving their absorption.

Self-administration is an important market trend. Prefilled syringes, autoinjectors, pen injectors, wearable injectors and connected inhalers allow patients to receive treatment outside hospitals and clinics. These products can improve treatment adherence and reduce pressure on healthcare facilities. Demand for home-based care is therefore creating opportunities for simple, safe and digitally connected delivery devices.

Targeted and controlled-release technologies are also gaining importance. Nanoparticles, liposomes, microneedles, implants and long-acting injectable formulations can deliver medicines over an extended period or direct them toward specific tissues. These methods may reduce dosing frequency and unwanted side effects. Smart delivery systems incorporating sensors, mobile applications and dose-tracking functions are supporting remote patient monitoring.

Market expansion may be restrained by high product-development costs, complex manufacturing requirements and lengthy regulatory approval processes. Device failures, dosing errors and product recalls can create safety and commercial risks. Advanced drug delivery systems must also demonstrate compatibility with pharmaceutical formulations, reliable performance and cost-effectiveness. Limited healthcare access and reimbursement restrictions may affect adoption in developing markets.

North America benefits from strong pharmaceutical research, advanced healthcare infrastructure and early adoption of self-injection devices. Europe remains important for biologics and medical-device development. Asia-Pacific provides growth opportunities through expanding healthcare expenditure, pharmaceutical manufacturing and increasing chronic disease prevalence.

Acute Market Reports provides drug delivery market research covering administration routes, products, technologies, applications, end users, competitive developments and regional opportunities. These reports help pharmaceutical companies, device manufacturers, healthcare providers and investors evaluate market demand and growth prospects through 2035.